Role of aspirin in the primary prevention of cardiovascular disease in patients with hyperlipoproteinaemia(a)

Role of aspirin in the primary prevention of cardiovascular disease in patients with hyperlipoproteinaemia(a)

Lipoprotein(a) [Lp(a)] is a well-established cardiovascular disease (CVD) risk factor with elevated Lp(a) levels contributing to a higher incidence of atherosclerotic CVD (ASCVD). However, no Lp(a)-specific interventions are currently available in the primary CVD prevention in individuals with eleva...

Full description

Saved in:
Bibliographic Details
Main Authors: Eleni Giannopoulou, Loukianos S Rallidis, Donatos Tsamoulis, Maria Gianniou, Constantine E Kosmas
Format: Article
Language:English
Published: BioExcel Publishing Ltd 2024-12-01
Series:Drugs in Context
Subjects:
aspirin (asa)
cardiovascular disease
hyperlipoproteinaemia( a)
lipoprotein(a)
primary prevention
Online Access:https://www.drugsincontext.com/role-of-aspirin-in-the-primary-prevention-of-cardiovasculardisease-in-patients-with-hyperlipoproteinaemiaa/
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.drugsincontext.com/role-of-aspirin-in-the-primary-prevention-of-cardiovasculardisease-in-patients-with-hyperlipoproteinaemiaa/

Similar Items